Mint Tower Capital Management’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,250
| Closed | -$12K | – | 146 |
|
|
2024
Q4 | $12K | Hold |
2,250
| – | – | ﹤0.01% | 100 |
|
|
2024
Q3 | $1K | Hold |
2,250
| – | – | ﹤0.01% | 130 |
|
|
2024
Q2 | $13K | Hold |
2,250
| – | – | ﹤0.01% | 87 |
|
|
2024
Q1 | $13K | Hold |
2,250
| – | – | ﹤0.01% | 95 |
|
|
2023
Q4 | $35K | Buy |
+2,250
| New | +$35K | 0.01% | 84 |
|
|
2022
Q4 | – | Sell |
-19,460
| Closed | -$3.97M | – | 336 |
|
|
2022
Q3 | $3.97M | Hold |
19,460
| – | – | 0.31% | 55 |
|
|
2022
Q2 | $3.92M | Buy |
19,460
+15,595
| +403% | +$3.14M | 0.31% | 47 |
|
|
2022
Q1 | $780K | Buy |
3,865
+2,615
| +209% | +$528K | 0.07% | 153 |
|
|
2021
Q4 | $250K | Hold |
1,250
| – | – | 0.03% | 200 |
|
|
2021
Q3 | $249K | Buy |
+1,250
| New | +$249K | 0.03% | 178 |
|